Search
for
Sort by
Research 91–120 of 112
- Subject Index
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Common Skin Disorders in Pediatric Skin of Color
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Extra-nasal odorant receptors: molecular mechanisms and therapeutic implications
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- The Effect of Different Preoperative Depilation Ways on the Healing of Wounded Skin in Mice
- Dermoscopy and reflection confocal microscope features of pigmented prurigo
- Heterozygous Variants of the SLC39A4 Gene and Possible Increased Risk for Developing Acrodermatitis Enteropathica with Kaposi’s Varicelliform Eruption
- Update From Dermatology Nurses’ Association Convention 2025
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Combined Use of Aqueous Extracts and Polysaccharides from Angelica sinensis and Platycladus orientalis Treats Androgenetic Alopecia
- The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm